Bio-wearables are coming, and the pharmaceutical company announced that it is developing them

Text/Yangcheng Evening News all-media reporter Cheng Xinghuan

On the 7th, Abbott announced at the world's most influential technology event, the International Consumer Electronics Show (CES), that it is developing the future of bio-wearable devices, and Robert Ford, president and CEO of the company, said in his speech: "The power of technology makes medical and health management increasingly digital and personalized, helping individuals to better control their health, and creating common scenes and languages between patients and doctors. The future is here, the world is changing faster than you could imagine, and we're creating a whole new future. ”

Robert Ford, President and CEO of Abbott Corporation, delivered a keynote address at the International Consumer Electronics Show

In its presentation, Abbott announced that it is developing a new bio-wearable device called Lingo that can transform the body's unique language into practical data to help users track and measure their overall health. The device's sensor technology will track a variety of key human signals, such as glucose, ketone bodies and lactate levels, enabling measurement of alcohol levels in the body in the future.

Rofude added: "It's more like a window into your body. At any time, you can use technology to understand the body and its needs. Our vision is to put Lingo far beyond today's wearables, helping users proactively manage their health, nutrition and athletic performance. ”

The launch of Lingo will expand Abbott's portfolio in sensing technologies. As early as 2014, Abbott was the first to apply this technology to diabetes management, pioneering the use of a small sensor that implanted a probe painlessly into a patient's upper arm for glucose monitoring. At the event, Abbott also demonstrated the Instantaneous Sensor 2 Generation Scanned Glucose Monitoring System (FreeStyle Libre 2), which brings a more convenient life to patients. In 2020, Abbott released the Abbott Libre Sense Glucose Motion Biosensor in Europe. Lingo was designed to reach more people with glucose monitoring technology to help them manage their weight, improve sleep, enhance physical fitness and boost their brain power.

In addition to the glucose data, Abbott hopes to make Lingo a device that can measure more biomarkers. As a result, the company is developing technology to continuously track ketones and use dieting and weight loss-related insights to help understand exactly what factors contribute to the body's ketosis status. At the same time, lactic acid monitoring technology is also being used to continuously monitor the accumulation of lactic acid generated during exercise to help improve athletic performance.

Source | Yangcheng Evening News Yangcheng Pie

Image | Courtesy of respondents

Editor-in-charge | Damanman